One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.

被引:1
|
作者
Muramatsu, Takashi [1 ]
Onuma, Yoshinobu [2 ]
Van Geuns, Robert J. [3 ]
Chevalier, Bernard [4 ]
Patel, Tejas M. [5 ]
Seth, Ashok [6 ]
Diletti, Roberto [2 ]
Garcia-Garcia, Hector M. [1 ]
Dorange, Cecile [7 ]
Veldhof, Susan [7 ]
Cheong, Wai-Fung [8 ]
Whitbourn, Robert J. [9 ]
Bartorelli, Antonio L. [10 ]
Abizaid, Alexandre [11 ]
Serruys, Patrick W. [2 ]
机构
[1] Erasmus MC, Thoraxctr, Rotterdam, Netherlands
[2] Erasmus Univ, Thoraxctr, NL-3000 DR Rotterdam, Netherlands
[3] Erasmus MC, Rotterdam, Netherlands
[4] ICPS, Massy, France
[5] Apex Heart Inst, Ahmadabad, Gujarat, India
[6] Fortis Escorts Heart Inst, New Delhi 110025, India
[7] Abott Vasc Int BVBA, Diegem, Belgium
[8] Abbott Vasc, Santa Clara, CA USA
[9] St Vincents Hosp, Melbourne, Vic, Australia
[10] Univ Milan, Milan, Italy
[11] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
关键词
D O I
10.1016/j.jacc.2013.08.766
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:B12 / B13
页数:2
相关论文
共 50 条
  • [41] Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial
    Dudek, Dariusz
    Onuma, Yoshinobu
    Ormiston, John A.
    Thuesen, Leif
    Miquel-Hebert, Karine
    Serruys, Patrick W.
    EUROINTERVENTION, 2012, 7 (09) : 1060 - 1061
  • [42] Long-term clinical outcomes of patients treated with everolimus-eluting bioresorbable scaffolds during daily practice-2-year results from the ISAR-ABSORB Registry
    Wiebe, Jens
    Hoppmann, Petra
    Kufner, Sebastian
    Cassese, Salvatore
    Harada, Yukinori
    Colleran, Roisin
    Xhepa, Erion
    Repp, Janika
    Schneider, Simon
    Ibrahim, Tareq
    Schunkert, Heribert
    Laugwitz, Karl-Ludwig
    Kastrati, Adnan
    Byrne, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B24 - B24
  • [43] Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry
    Hoppmann, P.
    Kufner, S.
    Cassese, S.
    Wiebe, J.
    Schneider, S.
    Pinieck, S.
    Scheler, L.
    Bernlochner, I.
    Joner, M.
    Schunkert, H.
    Laugwitz, K-L.
    Kastrati, A.
    Byrne, R. A.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (05) : 822 - 829
  • [44] Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold
    Costa, Jose De Ribamar, Jr.
    Abizaid, Alexandre
    Bartorelli, Antonio L.
    Whitbourn, Robert
    van Geuns, Robert Jan
    Chevalier, Bernard
    Perin, Marcos
    Seth, Ashok
    Botelho, Roberto
    Serruys, Patrick W.
    EUROINTERVENTION, 2015, 11 (02) : 141 - 148
  • [45] Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS
    T. M. Hommels
    R. S. Hermanides
    B. Berta
    E. Fabris
    G. De Luca
    E. H. Ploumen
    C. von Birgelen
    E. Kedhi
    Cardiovascular Diabetology, 19
  • [46] Two-year clinical outcomes of patients treated with overlapping absorb scaffolds: An analysis of the ABSORB EXTEND single-arm study
    Ribamar Costa, J., Jr.
    Abizaid, Alexandre
    Bartorelli, Antonio L.
    Whitbourn, Robert
    Serruys, Patrick W.
    Smits, Pieter C.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 (07) : 1202 - 1209
  • [47] Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS
    Hommels, T. M.
    Hermanides, R. S.
    Berta, B.
    Fabris, E.
    De Luca, G.
    Ploumen, E. H.
    von Birgelen, C.
    Kedhi, E.
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [48] Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH)
    Simsek, Cihan
    Magro, Michael
    Onuma, Yoshinobu
    Boersma, Eric
    Smits, Peter
    Dorange, Cecile
    Veldhof, Susan
    Regar, Evelyn
    Serruys, Patrick W.
    van Geuns, Robert-Jan
    EUROINTERVENTION, 2014, 10 (02) : 236 - 240
  • [49] Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention 1-Year Results From the ABSORB III Trial
    Baron, Suzanne J.
    Lei, Yang
    Chinnakondepalli, Khaja
    Vilain, Katherine
    Magnuson, Elizabeth A.
    Kereiakes, Dean J.
    Ellis, Stephen G.
    Stone, Gregg W.
    Cohen, David J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (08) : 774 - 782
  • [50] Two-year Imaging Results of the Absorb Bioresorbable Everolimus Eluting Vascular Scaffold with Planned Overlapping from the ABSORB EXTEND Optical Coherence Tomography Subgroup
    Wu, Chiung-Jen
    Kao, Paul Hsien-Li
    Onuma, Yoshinobu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (17) : S40 - S40